- Provide better diagnostic tools that will enable healthcare professionals improve patient selection,
- Generate meaningful economic evidence to support reimbursement and drive utilization,
- Expand utilization of Aquadex in other areas of the hospital, and
- Expand the use of Aquadex in an outpatient setting.
For further information, please contact: Claudia Napal Drayton Chief Financial Officer Sunshine Heart, Inc. T: +1-952-345-4205 Investor RelationsSunshine Heart Inc.email@example.com